RightFit
RecruitingNot applicable

Supporting Medtronic 780G Insulin Pump Adoption in Latino Patients: A Spanish - Language Training Initiative

Who can join

As published by the study on ClinicalTrials.gov. "Not stated" means the study hasn't said — ask the study team.

Age
10 Years to 20 Years
Sex
All sexes
Healthy volunteers
Not accepted
Compensation
Not stated

Other requirements are listed under Eligibility below. Only the study team can confirm whether you can join.

What to expect

No one can promise a trial will help you personally — that is what the research is trying to find out.

What participation involves

  • Time periods mentioned: 8 months

Only what the study's summary and detailed description on ClinicalTrials.gov say. Time periods may describe the whole study or a part of it — ask the study team what applies to you.

Show the study's own words
  • "Participants will: * Use the Medtronic MiniMed 780G Automated Insulin Delivery system for eight months * Attend one in-person nutrition support and insulin pump start class * Participate in regular virtual check-ins with native Spanish-speaking study team members"
Compensation
Not stated
  • Study-related exams and procedures are typically provided at no cost. This is how many trials work in general — confirm the details for this study with the study team.
  • Participants are monitored closely by the research team throughout the study.
  • Some participants may receive access to an investigational treatment, which is still being studied.
  • Your participation helps researchers learn whether this approach could help future patients.

About this study

In plain language

This study tests whether training and support in Spanish, or English and Spanish, help Latino youth ages 10–20 with type 1 diabetes use the Medtronic MiniMed 780G insulin pump and improve their health. Participants will use this system, which delivers insulin automatically, for eight months. They will attend one in-person food and pump training class and have regular online check-ins with Spanish-speaking study staff.

This study plans to learn more about whether a support program delivered in Spanish or both English and Spanish for bilingual families helps Latino youth with Type 1 Diabetes (T1D) successfully use the Medtronic MiniMed 780G system. The main question it aims to answer is: Does a linguistically and culturally tailored onboarding model for an automated insulin delivery system close the gap in technology adoption and improve health outcomes? Participants will: * Use the Medtronic MiniMed 780G Automated Insulin Delivery system for eight months * Attend one in-person nutrition support and insulin pump start class * Participate in regular virtual check-ins with native Spanish-speaking study team members

Compensation is read from the study's own description and may be missing — always confirm with the study team.

Eligibility

Who can join

  • Be 10–20 years old.
  • Have type 1 diabetes.
  • Identify as Latino or Hispanic.
  • Currently use a diabetes treatment plan, such as daily insulin shots or a non-Medtronic automatic insulin delivery system.
  • Be willing to switch to and use the Medtronic MiniMed 780G system for the whole study.

Who can't join

  • Currently use any Medtronic technology.
  • Have had more than one episode of diabetic ketoacidosis (DKA) in the past 12 months. DKA is a dangerous buildup of acids in the blood caused by too little insulin.
  • Be currently pregnant, because safety information about this system during pregnancy is limited.
  • Have a serious medical condition that the study doctor thinks could affect participation or how study results are understood.
  • Be unable or unwilling to use the Medtronic MiniMed 780G system for the whole study.

Simplified for readability. The official criteria below are what the study team uses.

Official eligibility criteria

Inclusion Criteria: * Age 10 - 20 years old * Diagnosis of type 1 diabetes * Self-identify as Latino/Hispanic (determined via self-report and/or electronic health record) * Currently managing diabetes using any regimen, including multiple daily injections (MDI) or any non-Medtronic automated insulin delivery system * Willing to transition to and use the Medtronic MiniMed 780G system for the duration of the study Exclusion Criteria: * Current use of any Medtronic technology * More than 1 episode of diabetic ketoacidosis (DKA) within 12 months of study enrollment * Current pregnancy (self-reported), due to limited safety data for use of the Medtronic MiniMed 780G system during pregnancy * Presence of any significant medical condition that, in the opinion of the investigator, would interfere with study participation or data interpretation * Inability or unwillingness to use the Medtronic MiniMed 780G system for the duration of the study

Study sites (1)

CO